Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by Laparotomy
Launched by ELSAN · Nov 16, 2020
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing different surgical methods for treating prostate cancer, specifically looking at robot-assisted surgery, conventional laparoscopy (a type of minimally invasive surgery), and laparotomy (a more traditional open surgery). The goal is to understand which technique offers the best outcomes for patients, as there hasn't been enough research on the effectiveness of robotic surgery compared to the other methods. This study is important because it will help healthcare authorities make informed decisions about these surgical options and provide patients with reliable information.
To participate in this trial, you need to be a male patient who is scheduled for a radical prostatectomy, which is a surgery to remove the prostate gland. If you're between the ages of 65 and 74 and currently hospitalized for this surgery, you may be eligible. It's important to know that you can only join if you agree to participate and are not under specific legal protections or without health insurance coverage. If you take part, you'll have the opportunity to contribute to valuable research that could improve treatment options for prostate cancer in the future.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • patient hospitalized for a planned radical prostatectomy
- Exclusion Criteria:
- • Consent refusal from the patient
- • Patients protected by law (Art.L 1121-5, 1121-6, 1121-8 du Code de la santé publique)
- • Absence of a French Health Care Insurance coverage
About Elsan
Elsan is a leading healthcare organization specializing in the management and operation of private medical facilities, with a strong focus on enhancing patient care and clinical outcomes. With a commitment to innovation and excellence, Elsan conducts clinical trials that advance medical research and treatment options across various therapeutic areas. The organization emphasizes collaboration with healthcare professionals and researchers to ensure rigorous study design and ethical standards, ultimately aiming to contribute valuable insights to the medical community and improve patient health on a broader scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ollioules, , France
Agen, , France
Metz, , France
Avignon, , France
Nancy, , France
Valenciennes, , France
Vannes, , France
Soyaux, , France
Roanne, , France
Caen, , France
Toulouse, , France
Poitiers, , France
Nîmes, , France
Beaumont, , France
Besançon, , France
Bordeaux, , France
Brest, , France
Brive La Gaillarde, , France
Cabestany, , France
Carcassonne, , France
Clermont Ferrand, , France
Desertines, , France
Le Mans, , France
Limoges, , France
Limoges, , France
Nantes, , France
Saint Doulchard, , France
Stains, , France
Besançon, , France
La Seyne Sur Mer, , France
Patients applied
Trial Officials
Shahnaz KLOUCHE, MD
Study Director
Elsan
Pierre-Thierry PIECHAUD, MD
Principal Investigator
Elsan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials